TOI

Oncology Institute Inc

TOI, USA

The Oncology Institute, Inc., an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as educational seminars, support groups, counseling services, and 24/7 patient assistance services. The company also provides and manages clinical trials, palliative care programs, stem cell transplants services, other care delivery models associated with non-community-based academic, and tertiary care settings; and conducts clinical trials for a range of pharmaceutical, and medical device companies. It serves adult and senior cancer patients. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California.

https://theoncologyinstitute.com

Stock Price

$ 0.00

0% increase compared to yesterday.

Dividend

Frequency:

N/A

Rate:

N/A

Next Payout:

N/A
TOI
stock
TOI

The two sides of India’s stock market story Times of India

Read more →
TOI
stock
TOI

Oncology Institute Announces Board Member Resignation TipRanks

Read more →

Showing 2 of 10

Analyst Ratings & Sentiment

(Last Updated 2025-09-30)

Rating:

STRONG BUY

Target Price:

$7

Analyst Picks

Strong Buy

1

Buy

0

Hold

0

Sell

0

Strong Sell

0

Sentiment:

Bullish

Finn Analysis

(Last Updated 2025-09-30)

Health Score

Price to Book Ratio (P/B)

-

Very Low

-300.19

Low ≤ 1

High ≥ 3

Return on Equity (ROE)

-

Very High

134.46 %

Low ≤ 5%

High ≥ 25%

Return on Assets (ROA)

-

Very Low

-10.09 %

Low ≤ 2%

High ≥ 10%

Free Cash Flow - Revenue % (FCF)

-

Very Low

-9.69 %

Low ≤ 5%

High ≥ 15%

Investors

* Institutions hold a combined 36.36% of the total shares of Oncology Institute Inc

1.

Vanguard Group Inc

(4.5783%)

since

2025/06/30

2.

TIFF Advisory Services Inc

(3.8869%)

since

2025/06/30

3.

Deerfield Management Co

(3.5935%)

since

2025/06/30

4.

BlackRock Inc

(3.5366%)

since

2025/06/30

5.

Vanguard Total Stock Mkt Idx Inv

(3.0415%)

since

2025/07/31

6.

Balyasny Asset Management LLC

(2.6933%)

since

2025/06/30

7.

Marshall Wace Asset Management Ltd

(1.5795%)

since

2025/06/30

8.

iShares Russell 2000 ETF

(1.5708%)

since

2025/08/31

9.

Geode Capital Management, LLC

(1.3683%)

since

2025/06/30

10.

Wexford Capital LP

(1.1964%)

since

2025/06/30

11.

CenterBook Partners LP

(0.7656%)

since

2025/06/30

12.

State Street Corp

(0.6911%)

since

2025/06/30

13.

Fidelity Small Cap Index

(0.6332%)

since

2025/06/30

14.

Vanguard Institutional Extnd Mkt Idx Tr

(0.5849%)

since

2025/07/31

15.

iShares Russell 2000 Growth ETF

(0.5457%)

since

2025/08/31

16.

Renaissance Technologies Corp

(0.4893%)

since

2025/06/30

17.

UBS Group AG

(0.4496%)

since

2025/06/30

18.

Northern Trust Corp

(0.4399%)

since

2025/06/30

19.

Millennium Management LLC

(0.4331%)

since

2025/06/30

20.

FourWorld Capital Management LLC

(0.4189%)

since

2025/06/30

21.

Freegulliver, LLC

(0.3677%)

since

2025/06/30

22.

JOSH ARNOLD INVESTMENT CONSULTANT, LLC

(0.3114%)

since

2025/06/30

23.

Vanguard Russell 2000 ETF

(0.3013%)

since

2025/07/31

24.

Two Sigma Investments LLC

(0.2975%)

since

2025/06/30

25.

Fidelity Extended Market Index

(0.285%)

since

2025/07/31

26.

Manatuck Hill Partners LLC

(0.2672%)

since

2025/06/30

27.

Bank of New York Mellon Corp

(0.2659%)

since

2025/06/30

28.

State St Russell Sm Cap® Indx SL Cl I

(0.2228%)

since

2025/08/31

29.

IMC US Ultra Micro Cap

(0.1738%)

since

2025/07/31

30.

Schwab Small Cap Index

(0.1578%)

since

2025/07/31

31.

NT R2000 Index Fund - NL

(0.1527%)

since

2025/06/30

32.

Strategic Advisers U.S. Total Stock

(0.1445%)

since

2025/07/31

33.

iShares Micro-Cap ETF

(0.1428%)

since

2025/08/31

34.

NT R2000 Index Fund - DC - NL - 3

(0.1217%)

since

2025/06/30

35.

Extended Equity Market Fund K

(0.119%)

since

2025/06/30

36.

SPDR® Russell 2000 US Small Cap ETF

(0.1133%)

since

2025/08/31

37.

Pleiades Small Cap Equity A

(0.1118%)

since

2025/06/30

38.

iShares Russell 2000 Small-Cap Idx Instl

(0.1094%)

since

2025/07/31

39.

Russell 2500™ Index Fund F

(0.0994%)

since

2025/06/30

40.

Fidelity Total Market Index

(0.0964%)

since

2025/07/31

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

EPS ActualEPS EstimateEPS DifferenceSurprise Percent

Upcoming Earnings Release

Date

2025-12-31

EPS Estimate

-0.0767

Latest Release

Date

2025-09-30

EPS Actual

-0.14

EPS Estimate

-0.11

EPS Difference

-0.03

Surprise Percent

-27.2727%

Investing Fit Scorecard

(Last Updated 2025-09-30)

Deep Value
Weak Deep Value(0.5)
Defensive
Highly Defensive(7)
Dividend
Weak Dividend Profile(1.5)
Economic Moat
Some Competitive Advantage(5.3)
GARP
Fair GARP(3.5)
Growth
Moderate Growth(3.5)
Momentum
No Momentum(2.5)
Net Net
Not Undervalued (Net-Net)(0.5)
Quality
Low Quality Business(2.5)
Value
Overpriced(2.5)

Income Statement

(Last Updated 2025-09-30)

Revenue

$ 0

Cost Of Revenue

$ 0

Gross Profit

$ 0

Operating Expenses

$ 0

Operating Income

$ 0

Interest Expense

$ 0

Pretax Income

$ 0

Net Income

$ 0

Income Tax Expense

$ 0

EBITDA

$ 0

Total Other Income Expense Net

$ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2025-09-30)

Cash

$ 0

Short Term Investments

$ 0

Receivables

$ 0

Inventories

$ 0

Total Current Assets

$ 0

Property Plant Equipment

$ 0

Total Assets

$ 0

Payables

$ 0

Short Term Debt

$ 0

Long Term Debt

$ 0

Total Liabilities

$ 0

Equity

$ 0

Trend

Cash Flow

(Last Updated 2025-09-30)

Net Income

$ 0

Depreciation

$ 0

Change In Working Capital

$ 0

Cash From Operations

$ 0

Capital Expenditures

$ 0

Cash From Investing

$ 0

Cash From Financing

$ 0

Net Change In Cash

$ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.